Medical Device Network lists seven promising liquid biopsy companies participating in the ESMO Congress 2019 conference being held in September.
Liquid biopsy, a minimally invasive cancer diagnostic tool, has gained momentum in the last five years due to its advantages over the archaic painful procedure of solid tumour biopsy.













